observed in human studies following capsinoids ingestion [5] . Moreover, capsinoids claimed to 48 cause an acute increase of fat metabolism (energy expenditure) and fat oxidation during exercise, or 49 somehow can cause long-term adaptations that promote fat metabolism [6] . However, the vital 50 molecular mechanism remains under investigation, as CSN considering as an ergogenic aid to 51 enhance fat oxidation and boost energy. 
54
Glycogen concentration plays an important role in skeletal muscle metabolism and endurance 55 performance. The exercise-induced muscle fatigue was brought reduction in the rate of glycogen 56 breakdown occurring in exercising muscle fibers after prolonged intensity exercise. It has been 57 described that overexpression of GLUT4 enhances the capacity of muscle glycogen replenishment in 58 animal studies [7] . GLUT4 is upregulated by the phosphorylation and activation of Akt
59
(serine/threonine specific protein kinase), which directs the GLUT4 protein to plasma, and thus 60 promotes glucose transport [8, 9] . However, the ability of the constitutively active Akt to cause 61 GLUT4 translocation to the plasma membrane of human skeletal muscle during post-exercise 62 recovery need to be determined after capsinoids supplementation. Other studies reported that the 63 capsinoids intake would be able to enhance the VO2, and tendency for increase resting energy 64 expenditure and fat oxidation [10, 11] .
65
Despite CSN effects on fat oxidation, there is a dearth of reports to demonstrate whether CSN 66 could enhance the muscle glycogen resynthesis in exercised human skeletal muscle. We 67 hypothesized that oral post-exercise capsinoids administration may increase fat oxidation as well as 68 enhance glycogen replenish in exercised human skeletal muscle. Therefore, we conducted this study 69 to explore the evidence that post-exercise capsinoids supplementation could enhance glycogen 70 content in human skeletal muscle. We measured respiratory exchange ratio (RER), glucose response, 
102
Safety dosage is very important consideration whether CSN can be used as dietary supplement,
103
irrespective of whether it is physiologically effective. Previous study used a high dose of CSN (>150 104 mg/d) and showed without any adverse effects on human studies [12] . Therefore, we choose the 105 dose 12mg of CSN as an oral supplement, which is the similar dosage to Josse's human study [13] .
106
We further found no single adverse effects on all participants in this study. Total four capsules were 107 ingested immediately after a single bout of exercise. The CSN capsules were purchased from the 108 Ajinomoto Co Inc (Ajinomoto, Tokyo, Japan). According to manufacturer details each 3 mg of 109 capsinoids contained capsiate, dihidrocapsiate, and nordihydrocapsiate in a 7:2:1 ratio respectively.
110
Therefore, all participates were instructed to intake either four capsules of CSN (equally 12mg), or 111 capsules of placebo contained rapeseed oil mixture with medium-chain triglycerides. 
Capsinoids maitained stable blood glucose and insulin levels during post-exercise 180 recovery 181
Blood glucose and plasma insulin levels were determined before, immediately and every 30-min 182 after exercise in both CSN and placebo trials. Glucose and insulin levels were peaked at 30-min 183 following exercise and subsequently declined in both trials (Fig. 3A and 3B) . Noteworthy, blood 184 glucose concentrations in CSN trial during recovery were relatively lower than placebo, however,
185
these values are not statistically significant. Moreover, no significant differences in postprandial 186 glucose and insulin area under curve (GAUC and IAUC) were found after exercise with capsinoids 187 supplementation (Fig 3C and 3D) . 
191
expressed as mean ± SE, N = 9. *Significant difference against placebo (P < 0.05).
192

Caspisinoids unalter NEFA and glycerol concentrations following exercise 193
The effect of CSN on circulating concentrations of NEFA and glycerol were measured before and was not found in placebo trial (Fig. 5A) . We further determined the glycogen levels in biopsed 205 skeletal muscles. The results showed that the recovery rate of glycogen synthesis in vastus lateralis 206 during 3h post-exercise recovery was not significantly greater with CSN supplementation (Fig. 5B) .
207
Noteworthy, the increased muscle GLUT4 protein in CSN trial is inconsistent with glycogen 208 resynthesis in exercised skeletal muscle. Our findings unveiled that oral capsinoids intake 209 immediately after exercise was unable to restore or enhance the skeletal muscle glycogen levels in 210 young men.
211
(A) (B) 
Effect of capsinoids on p-Akt and Akt levels in biopsied skeletal muscle 215
Next we monitored the changes of p-Akt and Akt proteins in skeletal muscle immediately and 216 3h after exercise, and data presented as p-Akt/Akt ratio (Fig. 6) . No significant response of 
Discussion
228
In this human study for the first time, we demonstrated the acute effect of capsinoids 229 supplementation on fat oxidation and muscle glycogen resynthesis during post-exercise recovery.
230
We found that capsinoids supplementation immediately following exercise could able to increase 
299
Our study provided evidence that acute oral capsinoids supplementation could change energy 300 reliance on fat oxidation in exercised young adults. However, these metabolic consequences cannot 301 in turn to increase the muscle glycogen resynthesis during 3h post-exercise recovery period 302 following a carbohydrate meal. Biopsied muscle samples data showed that capsinoids increased the 303 muscle GLUT4 protein expression 3h after exercise without affecting the muscle glycogen levels.
304
Alternatively, no significant difference in p-Akt expression was observed at 0h and 3h between
